Schedule 13G ownership disclosure

Achieve Life Sciences Inc

Common Stock, par value $0.001 per share · CUSIP: 004468500

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Alyeska Investment Group, L.P.

    Shares: 2,982,722.00 · Class: 5.6%

  • Alyeska Fund GP, LLC

    Shares: 2,982,722.00 · Class: 5.6%

  • Anand Parekh

    Shares: 2,982,722.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-005187
Form type
SCHEDULE 13G/A
Filer
ACHIEVE LIFE SCIENCES, INC.
CIK
CIK 949858
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub